Literature DB >> 19926176

Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines.

Badri Narayan Acharya1, Deepika Saraswat, Mugdha Tiwari, Asish Kumar Shrivastava, Ramarao Ghorpade, Saroj Bapna, Mahabir Parshad Kaushik.   

Abstract

A series of 1,3,5-trisubstituted pyrazolines were synthesized and evaluated for in vitro antimalarial efficacy against chloroquine sensitive (MRC-02) as well as chloroquine resistant (RKL9) strains of Plasmodium falciparum. The activity was at nano molar concentration. beta-hematin formation inhibition activity (BHIA(50)) of the pyrazolines were determined and correlated with antimalarial activity. A reasonably good correlation (r=0.62) was observed between antimalarial activity (IC(50)) and BHIA(50). This suggests that antimalarial mode of action of this class of compounds appears to be similar to that of chloroquine and involves the inhibition of hemozoin formation. Some of the compounds were showing better antimalarial activity than chloroquine against resistant strain of P. falciparum and were also found active in the in vivo experiment. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19926176     DOI: 10.1016/j.ejmech.2009.10.023

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Hypervalent iodine-mediated Ritter-type amidation of terminal alkenes: The synthesis of isoxazoline and pyrazoline cores.

Authors:  Sang Won Park; Soong-Hyun Kim; Jaeyoung Song; Ga Young Park; Darong Kim; Tae-Gyu Nam; Ki Bum Hong
Journal:  Beilstein J Org Chem       Date:  2018-05-11       Impact factor: 2.883

2.  In vitro anti-malarial efficacy of chalcones: cytotoxicity profile, mechanism of action and their effect on erythrocytes.

Authors:  Shweta Sinha; Daniela I Batovska; Bikash Medhi; B D Radotra; Ashish Bhalla; Nadezhda Markova; Rakesh Sehgal
Journal:  Malar J       Date:  2019-12-16       Impact factor: 2.979

3.  Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds.

Authors:  Dao Ngoc Hien Tam; Gehad Mohamed Tawfik; Amr Ehab El-Qushayri; Ghaleb Muhammad Mehyar; Sedralmontaha Istanbuly; Sedighe Karimzadeh; Vo Linh Tu; Ranjit Tiwari; Truong Van Dat; Phuong Thuy Viet Nguyen; Kenji Hirayama; Nguyen Tien Huy
Journal:  Malar J       Date:  2020-08-21       Impact factor: 2.979

4.  Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon Dots as Nanocarrier.

Authors:  Eduardo A Veliz; Anastasiia Kaplina; Sajini D Hettiarachchi; Athina L Yoham; Carolina Matta; Sabrin Safar; Meghana Sankaran; Esther L Abadi; Emel Kirbas Cilingir; Frederic A Vallejo; Winston M Walters; Steven Vanni; Roger M Leblanc; Regina M Graham
Journal:  Pharmaceutics       Date:  2022-07-14       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.